ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,938Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 262

$453K Total Retail Price of All Prescriptions

Rank: 32 out of 262

508 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 508 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 8,674 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 629 559 1 2
SIMVASTATIN 441 389 2 1
FUROSEMIDE 422 373 3 4
OMEPRAZOLE 381 312 4 5
POTASSIUM CHLORIDE 345 318 5 10
AMLODIPINE BESYLATE 287 268 6 6
ATENOLOL 199 199 7 16
METOPROLOL SUCCINATE 180 172 8 11
GABAPENTIN 173 170 9 19
LISINOPRIL 169 157 10 3
TRIAMTERENE-HCTZ 164 161 11 32
ENALAPRIL MALEATE 151 149 12 27
METOPROLOL TARTRATE 148 148 13 8
SERTRALINE HCL 141 103 14 14
METFORMIN HCL 133 127 15 9
JANTOVEN 129 129 16 39
LOSARTAN POTASSIUM 128 128 17 17
HYDROCHLOROTHIAZIDE 125 113 18 7
ALENDRONATE SODIUM 124 113 19 21
ATORVASTATIN CALCIUM 119 112 20 13
ZOLPIDEM TARTRATE 113 111 21 26
GLIMEPIRIDE 111 105 22 45
TRAMADOL HCL 110 100 23 18
CITALOPRAM HBR 108 103 24 20
SPIRONOLACTONE 100 68 25 58
EVISTA 90 65 26 73
MIRTAZAPINE 87 87 27 35
MELOXICAM 81 81 28 54
PREDNISONE 80 76 29 29
DIGOXIN 77 77 30 28
WARFARIN SODIUM 77 73 30 12
DONEPEZIL HCL 77 77 30 23
ALLOPURINOL 74 61 33 22
PREMARIN 72 72 R 34 125
CRESTOR 69 69 35 30
AZITHROMYCIN 68 58 36 44
OXYBUTYNIN CHLORIDE ER 67 55 37 102
CIPROFLOXACIN HCL 66 56 38 55
ACETAMINOPHEN-CODEINE 65 59 S3 39 108
AMITRIPTYLINE HCL 64 49 R 40 68
ADVAIR DISKUS 63 55 41 34
NAPROXEN 62 44 42 122
NAMENDA 62 62 42 37
HYDROCODONE-ACETAMINOPHEN 58 37 S3 44 15
KLOR-CON M20 56 56 45 98
PRAVASTATIN SODIUM 54 50 46 41
BYSTOLIC 54 54 46 123
KLOR-CON 10 54 49 46 72
POLYETHYLENE GLYCOL 3350 54 27 46 42
BISOPROLOL-HYDROCHLOROTHIAZIDE 51 51 50 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.